Stemtech (STEK) Non-Current Assets (2012 - 2025)
Stemtech's (STEK) quarterly Non-Current Assets came in at $2.7 million in Q4 2025, down 5.87% year-on-year from $2.9 million in Q4 2024, and down 1.53% quarter-over-quarter from $2.7 million in Q3 2025.
Stemtech (STEK) Non-Current Assets (2012 - 2025) Analysis & Trends
Stemtech has disclosed Non-Current Assets across 11 years of filings, most recently posting $2.7 million for Q4 2025.
- Non-Current Assets for Q4 2025 came in at $2.7 million, down 5.87% year-over-year; the trailing twelve-month figure through Dec 2025 was $11.0 million (down 10.51% YoY), and the FY2025 annual result was $2.7 million, down 5.87% from the prior year.
- Non-Current Assets came in at $2.7 million for Q4 2025 at Stemtech, down from $2.7 million in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $4.1 million in Q3 2021 to a low of $2.7 million in Q4 2025.
- The 5-year median for Non-Current Assets is $3.5 million (2023), against an average of $3.4 million.
- Across the five-year window, Non-Current Assets slipped 18.53% in 2024 and fell 5.87% in 2025, its largest moves.
- Stemtech's Non-Current Assets stood at $4.1 million in 2021, then decreased by 11.3% to $3.7 million in 2022, then fell by 10.18% to $3.3 million in 2023, then dropped by 12.86% to $2.9 million in 2024, then retreated by 5.87% to $2.7 million in 2025.
- The last three Non-Current Assets figures came in at $2.7 million (Q4 2025), $2.7 million (Q3 2025), and $2.8 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 26.33 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 8.68 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 3.84 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 2.47 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 9.64 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 2.90 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 1.22 Bn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.40 Bn |
| 10 | Stemtech | - | - | 354,677.00 | 2.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.69 Mn |
| Sep 30, 2025 | 2.73 Mn |
| Jun 30, 2025 | 2.78 Mn |
| Mar 31, 2025 | 2.82 Mn |
| Dec 31, 2024 | 2.86 Mn |
| Jun 30, 2024 | 3.07 Mn |
| Mar 31, 2024 | 3.10 Mn |
| Dec 31, 2023 | 3.28 Mn |
| Sep 30, 2023 | 3.45 Mn |
| Jun 30, 2023 | 3.64 Mn |
| Mar 31, 2023 | 3.81 Mn |
| Dec 31, 2022 | 3.65 Mn |
| Sep 30, 2022 | 3.75 Mn |
| Jun 30, 2022 | 3.87 Mn |
| Mar 31, 2022 | 4.07 Mn |
| Dec 31, 2021 | 4.12 Mn |
| Sep 30, 2021 | 4.14 Mn |
| Nov 30, 2019 | 53.00 |
| Aug 31, 2019 | 907.00 |
| May 31, 2019 | 1,761.00 |